全文获取类型
收费全文 | 56125篇 |
免费 | 4293篇 |
国内免费 | 1536篇 |
出版年
2023年 | 771篇 |
2022年 | 764篇 |
2021年 | 1403篇 |
2020年 | 1901篇 |
2019年 | 2506篇 |
2018年 | 2229篇 |
2017年 | 1545篇 |
2016年 | 1518篇 |
2015年 | 1632篇 |
2014年 | 3458篇 |
2013年 | 4423篇 |
2012年 | 2528篇 |
2011年 | 3457篇 |
2010年 | 2617篇 |
2009年 | 2765篇 |
2008年 | 2970篇 |
2007年 | 2917篇 |
2006年 | 2490篇 |
2005年 | 2282篇 |
2004年 | 2047篇 |
2003年 | 1694篇 |
2002年 | 1500篇 |
2001年 | 915篇 |
2000年 | 709篇 |
1999年 | 704篇 |
1998年 | 598篇 |
1997年 | 487篇 |
1996年 | 505篇 |
1995年 | 584篇 |
1994年 | 580篇 |
1993年 | 463篇 |
1992年 | 428篇 |
1991年 | 388篇 |
1990年 | 303篇 |
1989年 | 286篇 |
1988年 | 232篇 |
1987年 | 252篇 |
1985年 | 433篇 |
1984年 | 612篇 |
1983年 | 505篇 |
1982年 | 545篇 |
1981年 | 449篇 |
1980年 | 435篇 |
1979年 | 342篇 |
1978年 | 272篇 |
1977年 | 266篇 |
1976年 | 276篇 |
1975年 | 226篇 |
1974年 | 198篇 |
1973年 | 200篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的:探讨siRNA 沉默整合素茁1 基因对子宫内膜癌细胞侵袭、转移的影响。方法:选取子宫内膜癌ECC-1细胞系(ER阳性)
和KLE细胞系(ER阴性),分别转染Integrin beta1 siRNA 质粒(Integrin beta1 siRNA 组)、无义序列siRNA质粒(无义序列对照组)和空载
质粒(空载对照组),利用实时荧光定量PCR 检测各组细胞中Integrin 茁1 mRNA的表达,Western blot 检测各组细胞中Integrin beta1、
beta-catenin 和C-Myc 蛋白的表达,Transwell 小室检测各组细胞迁移和侵袭能力,MTT 法检测各组细胞的增殖情况。结果:Integrin
beta1 siRNA 组ECC-1 细胞和KLE 细胞中Integrin beta1 mRNA 和蛋白相对表达量均低于无义序列对照组和空载对照组(P<0.05);
Integrin beta 1 siRNA组ECC-1 细胞和KLE细胞中beta-catenin 蛋白和C-Myc 蛋白相对表达量均低于无义序列对照组和空载对照组,
差异均有统计学意义(P<0.05);Integrin beta1 siRNA组ECC-1 细胞和KLE 细胞中迁移细胞数和侵袭细胞数均低于无义序列对照组
和空载对照组(P<0.05);Integrin beta1 siRNA 组ECC-1细胞和KLE 细胞的A 值均低于无义序列对照组和空载对照组(P<0.05)。结
论:特异性抑制Integrin beta1 基因可抑制子宫内膜癌细胞迁移、侵袭和增殖,可能与抑制Wnt信号传导有关。 相似文献
2.
3.
《Bioorganic & medicinal chemistry》2020,28(22):115739
N-phenyl ureidobenzenesulfonates (PUB-SOs) is a new class of promising anticancer agents inducing replication stresses and cell cycle arrest in S-phase. However, the pharmacological target of PUB-SOs was still unidentified. Consequently, the objective of the present study was to identify and confirm the pharmacological target of the prototypical PUB-SO named 2-ethylphenyl 4-(3-ethylureido)benzenesulfonate (SFOM-0046) leading to the cell cycle arrest in S-phase. The antiproliferative and the cytotoxic activities of SFOM-0046 were characterized using the NCI-60 screening program and its fingerprint was analyzed by COMPARE algorithm. Then, human dihydroorotate dehydrogenase (hDHODH) colorimetric assay, uridine rescuing cell proliferation and molecular docking in the brequinar-binding site were performed. As a result, SFOM-0046 exhibited a mean antiproliferative activity of 3.5 μM in the NCI-60 screening program and evidenced that leukemia and colon cancer cell panels were more sensitive to SFOM-0046. COMPARE algorithm showed that the SFOM-0046 cytotoxic profile is equivalent to the ones of brequinar and dichloroallyl lawsone, two inhibitors of hDHODH. SFOM-0046 inhibited the hDHODH in the low nanomolar range (IC50 = 72 nM) and uridine rescued the cell proliferation of HT-29, HT-1080, M21 and MCF-7 cancer cell lines in the presence of SFOM-0046. Finally, molecular docking showed a binding pose of SFOM-0046 interacting with Met43 and Phe62 present in the brequinar-binding site. In conclusion, PUB-SOs and notably SFOM-0046 are new small molecules hDHODH inhibitors triggering replication stresses and S-phase arrest. 相似文献
4.
《Bioorganic & medicinal chemistry》2020,28(11):115492
Effective chemotherapy for solid cancers is challenging due to a limitation in permeation that prevents anticancer drugs from reaching the center of the tumor, therefore unable to limit cancer cell growth. To circumvent this issue, we planned to apply the drugs directly at the center by first collapsing the outer structure. For this, we focused on cell–cell communication (CCC) between N-glycans and proteins at the tumor cell surface. Mature N-glycans establish CCC; however, CCC is hindered when numerous immature N-glycans are present at the cell surface. Inhibition of Golgi mannosidases (GMs) results in the transport of immature N-glycans to the cell surface. This can be employed to disrupt CCC. Here, we describe the molecular design and synthesis of an improved GM inhibitor with a non-sugar mimic scaffold that was screened from a compound library. The synthesized compounds were tested for enzyme inhibition ability and inhibition of spheroid formation using cell-based methods. Most of the compounds designed and synthesized exhibited GM inhibition at the cellular level. Of those, AR524 had higher inhibitory activity than a known GM inhibitor, kifunensine. Moreover, AR524 inhibited spheroid formation of human malignant cells at low concentration (10 µM), based on the disruption of CCC by GM inhibition. 相似文献
5.
6.
《Peptides》2015
A new peptide with 61 amino acids cross-linked by 4 disulfide bridges, with molecular weight of 6938.12 Da, and an amidated C-terminal amino acid residue was purified and characterized. The primary structure was obtained by direct Edman degradation and sequencing its gene. The peptide is lethal to mammals and was shown to be similar (95% identity) to toxin Ts1 (gamma toxin) from the Brazilian scorpion Tityus serrulatus; it was named Tt1g (from T. trivittatus toxin 1 gamma-like). Tt1g was assayed on several sub-types of Na+-channels showing displacement of the currents to more negative voltages, being the hNav1.3 the most affected channel. This toxin displays characteristics typical to the β-type sodium scorpion toxins. Lethality tests and physiological assays indicate that this peptide is probably the most important toxic component of this species of scorpion, known for causing human fatalities in the South American continent. 相似文献
7.
Transient Receptor Potential, Melastatin-related, member 4 (TRPM4) channels are Ca2+-activated Ca2+-impermeable cation channels. These channels are expressed in various types of mammalian tissues including the brain and are implicated in many diverse physiological and pathophysiological conditions. In the past several years, the trafficking processes and regulatory mechanism of these channels and their interacting proteins have been uncovered. Here in this minireview, we summarize the current understanding of the trafficking mechanism of TRPM4 channels on the plasma membrane as well as heteromeric complex formation via protein interactions. We also describe physiological implications of protein-TRPM4 interactions and suggest TRPM4 channels as therapeutic targets in many related diseases. [BMB Reports 2015; 48(1): 1-5] 相似文献
8.
《Bioorganic & medicinal chemistry》2014,22(19):5368-5377
In order to identify compounds selective for the GluK1 and GluK3 subtypes of kainate receptors we have designed and synthesized a series of (S)-2-amino-3-((2-carboxyethyl)phenyl)propanoic acid analogs with hydrogen bond donating and accepting substituents on the aromatic ring. Based on crystal structures of GluK1 in complex with related ligands, the compounds were designed to explore possible interactions with non-conserved residues outside the glutamate ligand binding site and challenge the water binding network. Apart from obtaining GluK1 selective antagonists one analog with a phenyl-substituted urea (compound 31) showed some preference for GluK3 over GluK1-receptors. Docking studies indicate that this preference may be attributed to contacts between the NH of the urea substituent and non-conserved Ser741 and Ser761 residues. 相似文献
9.
10.